431 related articles for article (PubMed ID: 26358656)
1. Intracellular delivery of nanocarriers and targeting to subcellular organelles.
Jhaveri A; Torchilin V
Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656
[TBL] [Abstract][Full Text] [Related]
2. [Advances in the study of organelles targeting nanocarriers].
Sun XY; Wei LL; Chen HL; Liang WQ
Yao Xue Xue Bao; 2009 Aug; 44(8):838-44. PubMed ID: 20055149
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides with intracellular organelle targeting.
Cerrato CP; Künnapuu K; Langel Ü
Expert Opin Drug Deliv; 2017 Feb; 14(2):245-255. PubMed ID: 27426871
[TBL] [Abstract][Full Text] [Related]
4. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
Maity AR; Stepensky D
Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
Torchilin VP
Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
[TBL] [Abstract][Full Text] [Related]
7. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.
Chernenko T; Sawant RR; Miljkovic M; Quintero L; Diem M; Torchilin V
Mol Pharm; 2012 Apr; 9(4):930-6. PubMed ID: 22376068
[TBL] [Abstract][Full Text] [Related]
8. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
9. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
10. Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.
Munsell EV; Ross NL; Sullivan MO
Curr Pharm Des; 2016; 22(9):1227-44. PubMed ID: 26675220
[TBL] [Abstract][Full Text] [Related]
11. Nanopreparations for organelle-specific delivery in cancer.
Biswas S; Torchilin VP
Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
[TBL] [Abstract][Full Text] [Related]
12. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?
Field LD; Delehanty JB; Chen Y; Medintz IL
Acc Chem Res; 2015 May; 48(5):1380-90. PubMed ID: 25853734
[TBL] [Abstract][Full Text] [Related]
13. Advances in an active and passive targeting to tumor and adipose tissues.
Sakurai Y; Kajimoto K; Hatakeyama H; Harashima H
Expert Opin Drug Deliv; 2015 Jan; 12(1):41-52. PubMed ID: 25376864
[TBL] [Abstract][Full Text] [Related]
14. The ligand nanoparticle conjugation approach for targeted cancer therapy.
Karra N; Benita S
Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
[TBL] [Abstract][Full Text] [Related]
15. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
16. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.
Jain A; Jain A; Parajuli P; Mishra V; Ghoshal G; Singh B; Shivhare US; Katare OP; Kesharwani P
Drug Discov Today; 2018 May; 23(5):960-973. PubMed ID: 29129804
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
19. Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.
Agarwal R; Roy K
Ther Deliv; 2013 Jun; 4(6):705-23. PubMed ID: 23738668
[TBL] [Abstract][Full Text] [Related]
20. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
